lipoxin a4 has been researched along with Hyperoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chong, L; Li, C; Shao, Y; Wu, Q | 1 |
| Freedman, SD; Gilkey, C; Hasturk, H; Kantarci, A; Martin, CR; Salguero, MV; Van Dyke, TE; Zaman, MM | 1 |
2 other study(ies) available for lipoxin a4 and Hyperoxia
| Article | Year |
|---|---|
Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Hyperoxia; Lipoxins; Lung; Lung Injury; Protein Kinases; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Docosahexaenoic Acids; Female; Hyperoxia; Lipoxins; Lung Injury; Male; Mice; Mice, Inbred C57BL; Pulmonary Alveoli | 2014 |